Keyphrases
1-year Mortality
18%
Acinetobacter Baumannii (A. baumannii)
28%
Antimicrobial Resistance
34%
Bacteremia
41%
Bloodstream Infection
86%
Carbapenem Resistance
31%
Carbapenem-resistant Acinetobacter Baumannii
50%
Carbapenem-resistant Enterobacteriaceae
35%
Carbapenemases
25%
Cholesterol
17%
Clinical Characteristics
23%
Clostridium Difficile Infection
23%
Colistin
17%
Comorbidity
15%
Dextran Sulfate Sodium
23%
Enterobacteriaceae
18%
Erythrocytes
26%
Escherichia Coli
60%
Extended-spectrum-lactamase
25%
Fecal Carriage
25%
Fibrinogen
17%
Fourier Transform Infrared Spectroscopy (FT-IR)
16%
Hospital Admission
36%
Hospital-onset
30%
Hospitalized Patients
25%
Infection Control
16%
Infection Rate
15%
Israel
100%
Israeli
18%
Klebsiella Pneumoniae (K. pneumoniae)
19%
KPC-2
24%
LDL Apheresis
17%
Lipoproteins
17%
Medical Ward
15%
Multidrug-resistant
17%
National Cohort Study
24%
Neonatal Intensive Care Unit
49%
Odds Ratio
18%
OXA-48
23%
Peripheral Blood
28%
Plasmid
18%
Population-based Study
23%
Producing Escherichia Coli
21%
Pseudomonas Aeruginosa (P. aeruginosa)
27%
Red Blood Cell Aggregation
23%
Risk Factors
37%
Sentinel
22%
Tel Aviv
22%
Triglycerides
14%
Vancomycin-resistant Enterococci
25%
Medicine and Dentistry
Acinetobacter Baumannii
37%
Adenosine Triphosphate
11%
Antibiotic Resistance
32%
Antibiotics
26%
Atherosclerosis
11%
Bacteremia
18%
Bloodstream Infection
51%
Carbapenem
42%
Carbapenem-Resistant Enterobacteriaceae
35%
Carbapenemase
24%
Clostridium Difficile Infection
11%
Cohort Analysis
13%
Cohort Effect
14%
Congenital Tuberculosis
11%
COVID-19
11%
DNA Sequence
11%
Drug Therapy
14%
Effusion
11%
Endoscope
11%
Enterobacteriaceae
14%
Enterococcus faecium
25%
Escherichia coli
49%
Extended Spectrum Beta Lactamase
16%
Extended Spectrum Beta Lactamase Producing Escherichia Coli
11%
Extended Spectrum Beta Lactamase Producing Klebsiella Pneumoniae
11%
Genome Sequencing
11%
Heat Tolerance
11%
Hysterectomy
14%
Infection
46%
Infection Control
25%
Intensive Care
15%
Intensive Care Unit
22%
Laboratory Diagnosis
11%
LDL Apheresis
11%
Leg
11%
Meningitis
11%
Neonatal Intensive Care Unit
35%
Newborn Intensive Care
14%
Pathogen
24%
Patient Isolation
11%
Penicillinase
27%
Peptoclostridium difficile
11%
Peripheral Vascular Disease
11%
Polymerase Chain Reaction
16%
Ribosome DNA
11%
Risk Perception
11%
Thorax Radiography
11%
Vancomycin Resistant Enterococcus
25%
Wound
14%
Wound Infection
11%
Pharmacology, Toxicology and Pharmaceutical Science
2009 H1N1 Influenza
11%
Acinetobacter Baumannii
39%
Acinetobacter Infection
7%
Adverse Outcome
14%
Antibiotic Agent
10%
Antibiotic Resistance
9%
Antibiotics
33%
Antimicrobial Resistance
32%
Antimicrobial Therapy
15%
Atherosclerosis
11%
Bacteremia
41%
Bacterial Infection
11%
Bloodstream Infection
74%
Carbapenem
30%
Carbapenemase
23%
Cerivastatin
11%
Clostridium Difficile Infection
11%
Cohort Study
13%
Comorbidity
9%
Coronavirinae
11%
Dextran Sulfate
11%
Diarrhea
11%
Diclofenac
11%
Disease
15%
Enterobacter
11%
Enterobacteriaceae
16%
Epidemiology
11%
Escherichia coli
56%
Extended Spectrum Beta Lactamase
23%
Fibrinogen
11%
Fourier Transform Infrared Spectroscopy
11%
Gram Negative Sepsis
11%
Homocysteine
11%
Hypercholesterolemia
13%
Infection
48%
Infectious Agent
10%
Klebsiella
13%
Lactam
14%
Lipoprotein
11%
Low Density Lipoprotein
11%
Lung Tuberculosis
11%
Microorganism
11%
Penicillinase
27%
Peptoclostridium difficile
11%
Pseudomonas aeruginosa
29%
Quinolone Derivative
11%
Rhabdomyolysis
11%
Syndrome
13%
Tuberculosis
11%
Wound Infection
11%